Litcius/Paper detail

Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells

Rowa Y. Alhabbab

2020Frontiers in Genetics51 citationsDOIOpen Access PDF

Abstract

, the interaction between CSCs and the immune system, CAR T cell genetic engineering and signaling, CAR T cells in targeting CSCs, and the barriers in using CAR T cells as immunotherapy to treat solid cancers.

Topics & Concepts

Chimeric antigen receptorCancer stem cellCD44Cancer researchStem cellCancerCD90AntigenCancer cellCancer immunotherapyImmunotherapyBiologyImmunologyImmune systemCellCell biologyGeneticsCAR-T cell therapy researchImmunotherapy and Immune ResponsesCancer Cells and Metastasis
Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells | Litcius